Vol. 8 No. 2
Winthrop Dedicates The New Life Center for Labor/Delivery/Recovery
Multiple Sclerosis Treatment Program Opens at Winthrop
Elected Officials Congratulate Winthrop-University Hospital on Receiving New York's Largest Individual Hospital Award from the New York State Health Workforce Retraining Initiative
Winthrop is Designated a Community Training Center for Life Support
Winthrop-University Hospital's Stroke Team....A Team Approach to Saving Lives
Winthrop Opens New Breast HealthCare Program Educational Health Forums Are Planned for October
Winthrop's Center for Crohn's Disease and Colitis Helps Patients Achieve Relief and Remission
Winthrop's Pulmonary Rehabilitation Program and Lung Center Participate in a Prestigious International Trial
Winthrop Home Health Care Gives People the Option of Living at Home - Rather than in a Long Term Care or Skilled Nursing Facility
Winthrop Dedicates The New Life Center
Dr. Douglas Katz Is a Co-Developer of CTVPA:
A Modification of Spiral CT Scanning of the Chest for Suspected Blood Clots
A Third Cardiac Catheterization Laboratory Opens at Winthrop
Pediatric Cardiology at Winthrop
Women's Cardiology Program at Winthrop-University Hospital Takes Three-Pronged Approach
Winthrop's First Multiple Myeloma Patient Acheives Complete Remission through Stem Cell Autologous Transplantation Therapy
Perspectives In Health
Back to Publications
pproximately two million people in the United States suffer from Inflammatory Bowel Disease - IBD. Among the most common forms of IBD are Crohn's disease and ulcerative colitis, with 30,000 new cases diagnosed annually. Malnourishment and manifestations of liver disease are potential complications. And the growth and development of children and adolescents with IBD may be severely compromised if appropriate treatment is not administered in a timely fashion.
Under the experienced direction of Robert Burakoff, MD, Chief of the Division of Gastroenterology, Hepatology, and Nutrition, Winthrop's Center for Crohn's Disease and Colitis provides diagnosis - including endoscopic procedures; caring, individualized treatment; nutritional support; and an opportunity to participate in pharmaceutical trials of new drugs, currently being investigated in an array of prominent medical centers.
If the IBD patient is a child or adolescent, The Center's pediatric team, overseen by Robbyn Sockolow, MD, Chief of the Pediatric Gastroenterology and Nutrition Division, provides expert care. As IBD may be accompanied with nutritional issues, which affect the pediatric patients' growth and development, Dr. Sockolow and her team aggressively evaluate each patient's nutri- tional status, focusing on the management of food specific intolerances, home TPN (total parenteral nutrition, used to provide calories, protein, vitamins, and minerals to patients through a catheter, for those who cannot be fed via the gastrointestinal tract), and enteral feedings.
Robert Burakoff, MD, Chief of the Division of Gastroenterology, Hepatology, and Nutrition (R) and Robbyn Sockolow, MD, Chief of the Pediatric Gastroenterology and Nutrition Division (L), shown in Winthrop's Endoscopy Suite, provide expert care for adults and children through Winthrop's Center for Crohn's Disease and Colitis.
IBD can negatively affect adult nourishment, as well. Therefore,
the Center's Nutrition Support Team, under the supervision of a Board Certified Gastroenterologist and a Board Certified Nutrition Support Physician, evaluate patients' dietary management - especially for patients with advanced IBD and short bowel syndrome.
A chronic, relapsing, inflammatory, autoimmune disorder, Crohn's disease inflames and ulcerates the small intestine. Many patients experience peak disease activity in their early twenties. Crohn's disease thickens the wall of the small intestine with an acute and chronic inflammatory infiltrate, against which the body mounts an immune reaction - sending white blood and plasma cells to coat the intestinal walls. Nonetheless, the weakened, inflamed intestinal wall can perforate and form cracks, usually around the anus, or form a fistulous tract - an abnormal passageway - that can extend from a hole in the intestine out to the anus or nearby skin. Crohn's disease is not only painful, but creates severe difficulties in digestion and excretion, with watery stools as an early telltale symptom.
Inflaming and ulcerating the colon and rectum, ulcerative colitis is characterized by abdominal pain with cramping, diarrhea, malabsorption of nutrients, and weight loss. Stools may appear bloody and watery, and filled with mucous. The cause of ulcerative colitis is unknown. Patients with an aggressive form of ulcerative colitis may suffer debilitating complications, including anemia, weight loss, arthritis, and eventually cancer, which can arise from ulcers that have persisted for longer than a decade.
At Winthrop: Comprehensive Treatment, Pharmaceutical Trials, and Continuing Research
At Winthrop's Center for Crohn's disease and Colitis, a team of Board Certified gastroenterologists, nurses, dietitians, and researchers diagnose, treat, and monitor each case with individualized care, therapy, and concern. Aggressive medical therapy is usually required to enable the patient to obtain a clinical remission - therapy which must continue throughout the patient's normal life span.
Standard pharmaceutical treatment includes the administration of a variety of anti-inflammatory drugs. Patients who fail to respond or show intolerance to these drugs are treated with alternate therapies, including immunosuppressive therapy, antibiotics, methotrexate, the newer 5-aminosalicyclates, and are often supplemented with enteral and parenteral nutritional support.
Eligible patients also benefit from Winthrop's participation in prestigious, multi-centered national trials for new drug therapies.
Additionally, Winthrop's Center for Crohn's Disease and Colitis maintains a basic science laboratory, dedicated to achieving a fuller understanding of the causes of IBD inflammation. It is known that IBD sufferers demonstrate a heightened presence of pro-inflammatory substances, such as cytokines and adhesion molecules, which normally regulate intestinal activity. Winthrop's researchers strive to magnify their understanding of the mechanisms underlying IBD, to aid in developing new therapies.
Many patients with IBD, who are treated individually and appropriately, can achieve clinical remission. Adolescents and children with IBD - when properly diagnosed, treated, and supported with individualized nutritional programs - develop and grow normally. Do you need help with IBD, or know an adult who does? Just contact Dr. Robert Burakoff at 516/663-2527. For further information on the treatment of pediatric and adolescent patients, please contact Dr. Robbyn Sockolow at 516/663-8534.